Evaluating the Efficacy of Lateral Heel Wedges of Osteoarthritis of the Knee
NCT ID: NCT02254473
Last Updated: 2019-09-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2014-08-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Shoes Insoles on Symptoms and Disease Progression in Knee Osteoarthritis
NCT00415259
Shoe Inserts for Treating Osteoarthritis of the Knee
NCT00032240
Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.
NCT03379168
Effect of Reparel Knee Sleeve With Knee Injection
NCT04859764
Gel-One Treatment in Knee Osteoarthritis
NCT01934218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wedge Insert
Patients will receive a wedge insert
Wedge Insert
Flat insert
Patients will receive a flat insert
Flat Insert
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wedge Insert
Flat Insert
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Range of motion knee-flexion beyond 100 degrees and not lacking more than 15 degrees of extension.
* Subtalar and forefoot motion permitting foot/ankle eversion with weight bearing.
* Sufficient shoe toe box height to allow space for the insole and therefore comfort and compliance.
* Passive laxity of medial capsule and collateral ligament by knee extension test.
Exclusion Criteria
* Knee Instability- medial pseudo-opening of greater than grade 1 or detectable Anterior-posterior instability.
* Less than Grade 4 Kellgren-Lawrence radiographic changes in the medial compartment of the knee39.
* Grade 2 or greater Kellgren-Lawrence radiographic39 involvement of the patellofemoral or lateral compartment.
* Inadequate knee range of motion
* Balance problems requiring the use of a walker or wheel chair - ambulation with aid
* Diabetics with peripheral neuropathy
* Knee surgery within the past year
* Intraarticular steroid injection or visco supplementation within 6 months
* Stiff subtalar or forefoot joints - clinical test
* Inadequate shoe toe box depth to accommodate the test or control inserts
* Charcot joint
* Fixed contracture of the medial capsule and/or collateral ligament- clinical test
30 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Minnesota Medical Foundation
OTHER
HealthPartners Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TRIA Orthopaedic Center
Bloomington, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1405M50501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.